![Rainer Fuchs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fuchs active positions
Companies | Position | Start | End |
---|---|---|---|
Egenix, Inc.
![]() Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Director/Board Member | 2012-11-04 | - |
Career history of Rainer Fuchs
Former positions of Rainer Fuchs
Companies | Position | Start | End |
---|---|---|---|
Escoublac, Inc.
![]() Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA. | President | - | - |
Provasculon, Inc.
![]() Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA. | Chairman | 2010-02-10 | - |
President | 2010-02-10 | - |
Statistics
International
United States | 4 |
Operational
President | 2 |
Chairman | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Provasculon, Inc.
![]() Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA. | Health Technology |
Escoublac, Inc.
![]() Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA. | Health Technology |
Egenix, Inc.
![]() Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
- Stock Market
- Insiders
- Rainer Fuchs
- Experience